The University of Kansas Medical Center is establishing a Midwest consortium as part of the National Institutes of Health’s All of Us Research Program. KU Medical Center and its partners will receive $6.3 million in initial funding, with the potential to renew the award every year for four years.
Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient undergoes surgery, and cancer stage at diagnosis continues to be a leading factor in determining a person’s survival rate for all types of cancer, according to the first-ever annual cancer report from the National Cancer Database.
